Your search for ESKD returned 20 results

Bardoxolone methyl does not reduce the risk of end-stage renal disease (ESRD) or cardiovascular death in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

For women with end-stage renal disease (ESRD), intensive hemodialysis is associated with improved pregnancy outcomes.

Lowering LDL cholesterol in patients with chronic kidney disease does not significantly benefit renal progression.

The likelihood of experiencing worse pain at six months post-surgery is increased with a waiting time of 12 weeks or more for elective surgical lumbar discectomy (ESLD).

Compromised kidneys significantly reduce survival and life expectancy in patients with systemic lupus erythematosus (SLE).

Screening not linked to improved patient survival after transplant; may delay time to listing, transplant

Few new end-stage renal disease (ESRD) patients are referred for kidney transplant evaluation within one year of starting treatment, although referral practices vary considerably.

Declines in the estimated glomerular filtration rate offer an earlier end point for studying the progression of chronic kidney disease.

Women aren’t treated with dialysis as often as men when they have end-stage renal disease, according to new research.

Pulmonary congestion can predict risk of death and cardiac events in patients with end-stage renal disease undergoing dialysis.